BSE - Free Realtime Quote INR

Metropolis Healthcare Limited (METROPOLIS.BO)

1,701.10
+36.65
+(2.20%)
As of 1:27:36 PM GMT+5:30. Market Open.
Loading Chart for METROPOLIS.BO
  • Previous Close 1,664.45
  • Open 1,699.75
  • Bid 1,702.90 x --
  • Ask 1,704.90 x --
  • Day's Range 1,665.05 - 1,714.00
  • 52 Week Range 1,383.70 - 2,306.85
  • Volume 1,827
  • Avg. Volume 2,591
  • Market Cap (intraday) 89.028B
  • Beta (5Y Monthly) 0.16
  • PE Ratio (TTM) 60.47
  • EPS (TTM) 28.13
  • Earnings Date Aug 8, 2025 - Aug 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Nov 17, 2023
  • 1y Target Est 1,943.53

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laboratory in, and clinical research services. Metropolis Healthcare Limited was founded in 1981 and is headquartered in Mumbai, India.

www.metropolisindia.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: METROPOLIS.BO

更多內容

Performance Overview: METROPOLIS.BO

Trailing total returns as of 6/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

METROPOLIS.BO
17.99%
S&P BSE SENSEX (^BSESN)
3.33%

1-Year Return

METROPOLIS.BO
11.41%
S&P BSE SENSEX (^BSESN)
5.59%

3-Year Return

METROPOLIS.BO
4.32%
S&P BSE SENSEX (^BSESN)
44.78%

5-Year Return

METROPOLIS.BO
18.90%
S&P BSE SENSEX (^BSESN)
136.71%

比較: METROPOLIS.BO

選擇以關鍵表現數據分析類似公司;最多可選擇 4 個股份。

Statistics: METROPOLIS.BO

更多內容

Valuation Measures

Annual
As of 6/2/2025
  • Market Cap

    86.22B

  • Enterprise Value

    87.01B

  • Trailing P/E

    59.13

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.44

  • Price/Book (mrq)

    6.48

  • Enterprise Value/Revenue

    6.54

  • Enterprise Value/EBITDA

    27.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.89%

  • Return on Assets (ttm)

    7.10%

  • Return on Equity (ttm)

    11.96%

  • Revenue (ttm)

    13.31B

  • Net Income Avi to Common (ttm)

    1.45B

  • Diluted EPS (ttm)

    28.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.18B

  • Total Debt/Equity (mrq)

    15.30%

  • Levered Free Cash Flow (ttm)

    1.63B

Research Analysis: METROPOLIS.BO

更多內容

Company Insights: METROPOLIS.BO

研究報告: METROPOLIS.BO

更多內容

People Also Watch